Categories: Analysts

Descartes Systems Group’s financing could really accelerate its growth, says Cantor Fitzgerald

Descartes CEO Ed Ryan.
What happens after Descartes Systems Group (TSX:DSG) deploys the $160-million it proposes to raise, Cantor Fitzgerald Canada analyst Blair Abernethy wonders aloud.

In a research update to clients this morning, Abernethy maintained his “Buy” rating and (US)$15.50 one-year target on Descartes. Because the financing has not closed, the analyst says he is not making changes to his estimates (he expects Descartes will post EBITDA of $51.6-million on revenue of $174.8-million in fiscal 2015 and EBITDA of $56.4mn on a topline of $190.2-million in 2016), but speculated as to what he company might look like post financing.

Yesterday, Descartes announced it will, through a syndicate of underwriters co-led by Morgan Stanley, Barclays and GMP Securities, sell 9.5-million common shares, plus an overallotment option of 1.425-million shares, for a total proceeds of a little more than $160-milion.

Abernethy envisioned a scenario in which the proceeds of yesterday’s proposed financing were deployed through acquisitions over the next year. Noting that Descartes has, historically, paid 8x-10x EBITDA for acquisitions, he notes that the same level would increase the company’s fiscal 2016 EBITDA by 24%-26%, up to $69.8 to $72.4-million. At the extreme ends of the spectrum, acquisitions done at 14x would increase EBITDA by 20%, to $67.9-million, and the bargain basement scenario of 6x would see a 47% bump in EBITDA, to $83.1-million.

For now, Abernethy notes that Descartes is currently trading at 17.1× his estimate of 2016 earnings, a multiple he says it deserves due to its solid margins, stable business model, and the cross-selling opportunities presented by its expanded product offering.

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: dsg
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Is Peloton Stock a Buy? (May, 2024)

Following news of a restructuring, Roth MKM analyst George Kelly has chopped his price target on Peloton (Peloton Stock Quote,… [Read More]

2 hours ago

Is Ascend Wellness stock a buy?

Ahead of the company's first quarter results, Beacon analyst Russell Stanley thinks Ascend Wellness (Ascend Wellness Stock Quote, Chart, News,… [Read More]

2 hours ago

Paradigm chops price target on Snipp Interactive

Following the company's fourth quarter results, Paradigm Capital analyst Daniel Rosenberg has cut his price target on Snipp Interactive (Snipp… [Read More]

3 hours ago

It’s time to buy cannabis stocks, this analyst says

A major development came down the pipe this week at the U.S. Drug Enforcement Agency has reportedly decided to reschedule… [Read More]

17 hours ago

Is Generac stock a buy?

Following the company's first quarter results, Roth MKM analyst Chip Moore remains neutral on Generac Holdings (Generac Holdings Stock Quote,… [Read More]

1 day ago

Bombardier is a buy, Desjardins says (May, 2024)

The stock has climbed slowly but surely since last October. But is there still money to be made on Bombardier?… [Read More]

1 day ago